European Approval Makes Atara’s Ebvallo™ First Allogeneic T-Cell Therapy Approved Worldwide


Atara Biotherapeutics’ Ebvallo™ (tabelecleucel) Receives European Commission Approval as First Ever Therapy for Adults and Children with EBV+ PTLD Represents First Approval of an Allogeneic T-Cell Immunotherapy Globally Pierre Fabre to Lead Commercialization and Distribution Activities in Europe THOUSAND OAKS, Calif. & CASTRES, France – Atara Biotherapeutics, Inc. (Nasdaq: ATRA) and Pierre Fabre today announced that the […]

International Congress Registration


International congress on the application of new technologies of stem cells and genetics in Personalized Medicine In the beautiful Kish Island It will be held for three days from March 8th -10th. Participating in the competition is optional for those researchers who are under 45 And those who are interested can send their abstracts to […]

crispr cas9 gene editing used cut out mutation early study


System shows proof-of-concept effects in reducing production of toxic molecules A CRISPR/Cas9 gene editing system can be used to remove the repeat expansion in the C9ORF72 gene, the most common genetic cause of amyotrophic lateral sclerosis (ALS), a new study reports. The system showed positive proof-of-concept effects in mouse models and in human cells, reducing the amount of faulty […]

Cancer Vaccine to Simultaneously Kill and Prevent Brain Cancer Developed


Summary: A new stem cell therapy approach eliminates established brain tumors and provides long-term immunity, training the immune system to prevent cancer from returning. Source: Brigham and Women’s Hospital Scientists are harnessing a new way to turn cancer cells into potent, anti-cancer agents. In the latest work from the lab of Khalid Shah, MS, Ph.D., at Brigham […]

Personalized Molecular Therapy

Personalized molecular therapy is a contemporary field of medicine whose primary goal is to target the molecular mechanisms involved in disease pathogenesis and development. Nowadays, advanced genomic and molecular technologies are operated to discover the specific molecular signatures of patients responsible for their diseases. This approach significantly improves the quality and efficacy of treatment, particularly […]

Personalized Cell Therapy

Personalized cell therapy is a modern treatment that uses the patient’s viable cells or grafts to regenerate damaged organs. A personalized cell therapy cycle consists of I) identifying the most appropriate cell type based on the type of disease, stage, etc., II) isolating and culturing the cells, and III) infusing the cells into the patient. […]

Personalized Reproductive Medicine

Personalized reproductive medicine is a modern field of individualized medicine that deals with diseases of the reproductive system and infertility. Other objectives of this field include the prevention of infertility and subsequent treatment of reproductive disorders. Many years of research into the human genome and genetics have led us to several vital variations and mutations […]

Personalized Cancer Medicine

Personalized cancer medicine refers to a novel approach to personalized medicine based on an individual’s genome and biological processes. Several investigations have confirmed that specific genes largely control therapeutic outcome in cancer patients and that mutations directly control all stages of cancer development, progression, and response. In personalized cancer medicine, we seek to discover all […]

Base Editing: A Strong Contender in Cell and Gene Therapy


Base editors, DNA double-strand break (DSB)-independent genome modification agents, have been recognized alongside prime editors as key technologies to watch this year,1 and advances to date have been encouraging. Although these technologies have yet to enter the clinic, the first candidate therapy received investigational new drug approval from the U.S. Food and Drug Administration in 2021—less […]

Enzyme that Promotes Diet-Induced Obesity Could Point to Inhibitor Therapy


High-fat diet (HFD) feeding in mice promotes induction of aldose reductase (AR) activity, expression, and senescence of adipocytes in subcutaneous adipose tissue (scAT), according to a new study in Obesity. The researchers, headed by a New York University Grossman School of Medicine team, suggest that their findings could point to potential new strategies for treating obesity. […]